Skip to content
10-K

Annual Report

BIOHEMP INTERNATIONAL, INC.

0001477932-19-000575

← back to feed
Filed
Feb 20, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2018 · Aug 31, 2018 −$84
Operating Cash Flow FY 2018 · Aug 31, 2017 −$76.7K
Stockholders Equity FY 2018 · Aug 31, 2018 −$236.45K
Stockholders Equity FY 2018 · Aug 31, 2017 −$191.46K
Stockholders Equity FY 2018 · Aug 31, 2016 −$81.14K
Current Liabilities FY 2018 · Aug 31, 2018 $236.45K
Current Liabilities FY 2018 · Aug 31, 2017 $191.55K
Total Liabilities FY 2018 · Aug 31, 2018 $236.45K
Total Liabilities FY 2018 · Aug 31, 2017 $191.55K
Net Income FY 2018 · Aug 31, 2018 −$44.99K
Net Income FY 2018 · Aug 31, 2018 −$445.8K
Net Income FY 2018 · Aug 31, 2017 −$110.32K
Shares Outstanding FY 2018 · Feb 11, 2018 32.52K sh
Current Assets FY 2018 · Aug 31, 2017 $84
Total Assets FY 2018 · Aug 31, 2017 $84